Page last updated: 2024-09-04

combivir and maraviroc

combivir has been researched along with maraviroc in 2 studies

Compound Research Comparison

Studies (combivir)	Trials (combivir)	Recent Studies (post-2010) (combivir)	Studies (maraviroc)	Trials (maraviroc)	Recent Studies (post-2010) (maraviroc)
122	32	59	785	124	539

Protein Interaction Comparison

Protein	Taxonomy	maraviroc (IC50)
Cytochrome P450 3A4	Homo sapiens (human)	3.1
Delta-type opioid receptor	Rattus norvegicus (Norway rat)	0.0014
C-C chemokine receptor type 5	Homo sapiens (human)	0.0044
C-C chemokine receptor type 5	Mus musculus (house mouse)	0.0052

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brumme, CJ; Chapman, D; Dong, W; Harrigan, PR; Heera, J; James, I; Lewis, M; McGovern, RA; Mo, T; Portsmouth, S; Thielen, A; Valdez, H; Woods, CK; Zhong, X	1

Trials

2 trial(s) available for combivir and maraviroc

Article	Year
96-Week MERIT ES analysis shows efficacy of Celsentri=Selzentry. AIDS patient care and STDs, 2009, Volume: 23, Issue:8 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclohexanes; Cyclopropanes; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Maraviroc; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Triazoles; Zidovudine	2009
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial. Journal of acquired immune deficiency syndromes (1999), 2012, Nov-01, Volume: 61, Issue:3 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Cyclohexanes; Drug Combinations; Drug Therapy, Combination; Female; Genotype; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Male; Maraviroc; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Viral Load; Viral Tropism; Young Adult; Zidovudine	2012

Article

Year

96-Week MERIT ES analysis shows efficacy of Celsentri=Selzentry.

AIDS patient care and STDs, 2009, Volume: 23, Issue:8

Topics: Alkynes; Anti-HIV Agents; Benzoxazines; CCR5 Receptor Antagonists; CD4 Lymphocyte Count; Cyclohexanes; Cyclopropanes; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Maraviroc; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Triazoles; Zidovudine

2009

Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial.

Journal of acquired immune deficiency syndromes (1999), 2012, Nov-01, Volume: 61, Issue:3

Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Cyclohexanes; Drug Combinations; Drug Therapy, Combination; Female; Genotype; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Lamivudine; Male; Maraviroc; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Viral Load; Viral Tropism; Young Adult; Zidovudine

2012